Device Trial Radar · NCT06976086
Pediatric Expansion Study of the Sentio System
Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Apr 30, 2025
Primary completion
Oct 1, 2026
Study completion Jul 1, 2027
Sponsor
- Lead sponsor
- Oticon MedicalNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Guy's and St Thomas' NHS Foundation Trust; Birmingham Women's and Children's NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust; University Medical Center Groningen; Radboud University Medical Center; Hospital Universitario La Fe; Hospital Universitario Virgen Macarena; Hospital Donostia
- First posted
- May 16, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 3 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is performed to collect safety and performance data supporting the use of the Sentio system in children below 12 years of age. The system is currently available on the market for patients 12 years and above. It is a prospective study conducted at eight European hospitals, aiming to treat 50 patients with a hearing loss than would benefit from treatment with a bone-anchored hearing system (BAHS). The primary objective of the study is to demonstrate that the Sentio system improves the hearing on the implanted ear, compared with the unaided situation.
Conditions
- Hearing Loss, Conductive
- Hearing Loss, Mixed
- Single Sided Deafness
Interventions
Active transcutaneous bone conduction systemDevice
The Sentio system consists of the Sentio 1 Mini sound processor (SP) and Sentio Ti implant with fixation band and screws.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Demonstrate that the Sentio system improves hearing on the implanted ear.Time frame: 3 months post-surgery
Locations
8 sites in 3 countries. Site status is shown where the registry gives one.
University Medical Center Groningen
Groningen, Netherlands
Radboud University Medical Center
Nijmegen, Netherlands
Hospital Universitario de Donostia
San Sebastián, Spain
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.